(Q40700170)

22 September 2017

title

Experimental utility of rabies virus-neutralizing human monoclonal antibodies in post-exposure prophylaxis (English)

1 reference

22 September 2017

0 references

rabies virus

1 reference

post-exposure prophylaxis

inferred from title

1 reference

inferred from title

author

Charles Edward Rupprecht

8

object named as

Rupprecht CE

1 reference

22 September 2017

6

Koprowski H

1 reference

22 September 2017

Hanlon CA

1

1 reference

22 September 2017

DeMattos CA

2

1 reference

22 September 2017

DeMattos CC

3

1 reference

22 September 2017

Niezgoda M

4

1 reference

22 September 2017

Hooper DC

5

1 reference

22 September 2017

Notkins A

7

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 July 2001

1 reference

22 September 2017

1 reference

22 September 2017

volume

19

1 reference

22 September 2017

issue

28-29

1 reference

22 September 2017

page(s)

3834-3842

1 reference

Failure of rabies postexposure treatment in Thailand

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900135-9

7 January 2021

Partial recovery from rabies in a nine-year-old boy

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900135-9

7 January 2021

Failure of postexposure treatment of rabies in children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900135-9

7 January 2021

Additional reports of failure to respond to treatment after rabies exposure in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900135-9

7 January 2021

Heterologous antisera and antivenins are essential biologicals: perspectives on a worldwide crisis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900135-9

7 January 2021

Human rabies postexposure prophylaxis during a raccoon rabies epizootic in New York, 1993 and 1994

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900135-9

7 January 2021

Mass human exposure to rabies in New Hampshire: exposures, treatment, and cost

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900135-9

7 January 2021

Causes, costs, and estimates of rabies postexposure prophylaxis treatments in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900135-9

7 January 2021

Development of Orphan Vaccines: An Industry Perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900135-9

7 January 2021

Encephalitis caused by a Lyssavirus in fruit bats in Australia

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900135-9

7 January 2021

Characterisation of a novel lyssavirus isolated from Pteropid bats in Australia.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900135-9

7 January 2021

Incidence of reactions to antirabies horse serum

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900135-9

7 January 2021

Capture of human monoclonal antibodies from cell culture supernatant by ion exchange media exhibiting high charge density

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900135-9

7 January 2021

Genetically engineered antibodies in gene transfer and gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900135-9

7 January 2021

Cell hybridization, hybridomas, and human hybridomas

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900135-9

7 January 2021

The development of monoclonal human rabies virus-neutralizing antibodies as a substitute for pooled human immune globulin in the prophylactic treatment of rabies virus exposure.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900135-9

7 January 2021

Epidemiology of human rabies in the United States, 1980 to 1996.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900135-9

7 January 2021

Human diploid cell culture rabies vaccine (HDCV) and purified chick embryo cell culture rabies vaccine (PCECV) both confer protective immunity against infection with the silver-haired bat rabies virus strain (SHBRV).

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900135-9

7 January 2021

Human monoclonal antibodies specific for the rabies virus glycoprotein and N protein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900135-9

7 January 2021

A Rabies-Specific Human Monoclonal Antibody That Protects Mice Against Lethal Rabies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900135-9

7 January 2021

Development of human monoclonal antibodies to rabies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900135-9

7 January 2021

Use of mouse anti-rabies monoclonal antibodies in postexposure treatment of rabies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900135-9

7 January 2021

Mechanisms of rabies virus neutralization by glycoprotein-specific monoclonal antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900135-9

7 January 2021

Human rabies immune globulin

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900135-9

7 January 2021

Clonal analysis of a human antibody response. Quantitation of precursors of antibody-producing cells and generation and characterization of monoclonal IgM, IgG, and IgA to rabies virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900135-9

7 January 2021

Immunoglobulin (IgG) and (IgM) antibody responses to rabies vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900135-9

7 January 2021

Synergistic neutralization of simian-human immunodeficiency virus SHIV-vpu+ by triple and quadruple combinations of human monoclonal antibodies and high-titer anti-human immunodeficiency virus type 1 immunoglobulins

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900135-9

7 January 2021

10.1016/S0264-410X(01)00135-9

Identifiers

DOI

1 reference

22 September 2017

1 reference